NCT00004144View on ClinicalTrials.gov

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bryostatin 1

DRUG

gemcitabine hydrochloride

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00004144 - Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter